156.50 and dropping

Quote












anonymous said:
Wow, I bet you think tiny houses are the American dream. I'll buy 20,000 shares without blinking an eye. I did a large cap scan ($10B mkt cap, 500k avg vol)...it generated 20 names... I sorted it for % upside & SHPG ranked #2 w/ 51% upside very Bullish. SHPG need a major RIF and WARN for the bloated weak sales force. Hire contracted reps and give us shareholders something for our investment.
To hell with you lazy whining two bit slouches.
Click to expand...

Looks like you were right and the angry clown was wrong !
Shire PLC (ADR)
NASDAQ: SHPG - Aug 17, 10:00 AM EDT
$150.71 USD UP $2.27 (1.53%)
 






anonymous said:
Looks like you were right and the angry clown was wrong !
Shire PLC (ADR)
NASDAQ: SHPG - Aug 17, 10:00 AM EDT
$150.71 USD UP $2.27 (1.53%)
Click to expand...

After this idiot of a CEO has tanked the stock 40% u r happy with 1% growth???it is actually .75 as of now.... dropped a little since you posted your ridiculous comment. U belong with flem. Both are not business smart
 






No dickhead, I made millions on ABBV after failed shire acquisition. That's what killed your stock and it never recovered. Shire is a dog and I was just stating it's trading at discount to 5 years average historical P/E, and $150 is a fantastic entry point considering the possible spin into separate entities and potential outright sale.
FO had nothing to do with this dum dum !
 






Ornskov wasn't at fault !!!! The U.S. Inversion laws, Obama and U.S. DOJ caused your failed Shire deal, which in turn led Abbvie to redirect to Pharmacyclics and Stemcentrx acquisitions. The YUGE 1.6 Billion Shire break up fee we lost has already been recovered from superior product line. Shire would have brought little to nothing to Abbvies plate and would have been a big FAT disaster. We took the $54B for failed Shire and grabbed Pharmacyclics for $21B and Stemcentrx for $10.2B. That leaves $23B for future deals. Rova-T is the next Blockbuster and Imbruvica is kicking ass When shire got burnt on failed deal the stock plummeted from $262 in late 2014 and today is sitting @ $150. The $32 B paid for Baxalta was a big waste. When you guy get the next blockbuster like our Humira which ABBOTT and ABBVIE milked for over a decade and a half gimme a call. And YES shire is an excellent buy @ $150.
 












anonymous said:
Ornskov wasn't at fault !!!! The U.S. Inversion laws, Obama and U.S. DOJ caused your failed Shire deal, which in turn led Abbvie to redirect to Pharmacyclics and Stemcentrx acquisitions. The YUGE 1.6 Billion Shire break up fee we lost has already been recovered from superior product line. Shire would have brought little to nothing to Abbvies plate and would have been a big FAT disaster. We took the $54B for failed Shire and grabbed Pharmacyclics for $21B and Stemcentrx for $10.2B. That leaves $23B for future deals. Rova-T is the next Blockbuster and Imbruvica is kicking ass When shire got burnt on failed deal the stock plummeted from $262 in late 2014 and today is sitting @ $150. The $32 B paid for Baxalta was a big waste. When you guy get the next blockbuster like our Humira which ABBOTT and ABBVIE milked for over a decade and a half gimme a call. And YES shire is an excellent buy @ $150.
Click to expand...

Interesting so Flem wasn't responsible after all.
 






anonymous said:
Ornskov wasn't at fault !!!! The U.S. Inversion laws, Obama and U.S. DOJ caused your failed Shire deal, which in turn led Abbvie to redirect to Pharmacyclics and Stemcentrx acquisitions. The YUGE 1.6 Billion Shire break up fee we lost has already been recovered from superior product line. Shire would have brought little to nothing to Abbvies plate and would have been a big FAT disaster. We took the $54B for failed Shire and grabbed Pharmacyclics for $21B and Stemcentrx for $10.2B. That leaves $23B for future deals. Rova-T is the next Blockbuster and Imbruvica is kicking ass When shire got burnt on failed deal the stock plummeted from $262 in late 2014 and today is sitting @ $150. The $32 B paid for Baxalta was a big waste. When you guy get the next blockbuster like our Humira which ABBOTT and ABBVIE milked for over a decade and a half gimme a call. And YES shire is an excellent buy @ $150.
Click to expand...

Thanks for the rundown douche wagon. Since inception abbvie has underperformed both the s&p 500 and shire common stock (even with recent Flem drop). Go back to ur own board and give us a call when you outperform either one of those two benchmarks.
 






Lol. Left Shire a while back. Left Pharma before that. Checked out and did my own thing while these fools, the B&L crew, ran this company to the ground. 20 by 20...lol. With a debt load that is not manageable. Just remember, these ego maniac, company destroyers, only care about themselves. And it has given them wealth beyond our understanding. But at the cost of everyone around them. Someone please tell me otherwise if im mistaken.
 


















anonymous said:
No dickhead, I made millions on ABBV after failed shire acquisition. That's what killed your stock and it never recovered. Shire is a dog and I was just stating it's trading at discount to 5 years average historical P/E, and $150 is a fantastic entry point considering the possible spin into separate entities and potential outright sale.
FO had nothing to do with this dum dum !
Click to expand...

You didn't make a damn dime let alone millions. Fucking liar
 






Personally sold everything at $258 because I didn't want to be greedy. With salary, bonus, and those proceeds I made just under $400 grand for the year.
Grandstand, Talk shit, and Run your mouth all you want, there is no rep at AbbVie that can make claim to that kind of comp for 1 year of work.
 






anonymous said:
Personally sold everything at $258 because I didn't want to be greedy. With salary, bonus, and those proceeds I made just under $400 grand for the year.
Grandstand, Talk shit, and Run your mouth all you want, there is no rep at AbbVie that can make claim to that kind of comp for 1 year of work.
Click to expand...

So your meager shire salary At plan was $110 TOPS where did the other 290k come from ?
Haa Haa This is laughable and a fairy tale. "Those proceeds" were what ? vested options you exercised ? Not buying it bud.
 












anonymous said:
Thanks for the rundown douche wagon. Since inception abbvie has underperformed both the s&p 500 and shire common stock (even with recent Flem drop). Go back to ur own board and give us a call when you outperform either one of those two benchmarks.
Click to expand...

We outperformed you AND your stock !! PLUS, you're all going to be jobless after spin and sale and ABBVIE folks have a long run coming with the ONC and superb pipeline.
 
























Top Bottom
Back
Quote